Clinical outcomes of sirolimus-eluting stenting after rotational atherectomy

Circulation Journal

Volumn 73, Issue 11, 2009, Pages 2042-2049

  Tamekiyo, Hiromichi ^a   Hayashi, Yasuhiko ^a   Toyofuku, Mamoru ^a   Ueda, Hironori ^a   Sakuma, Tadamichi ^a   Okimoto, Tomokazu ^a   Otsuka, Masaya ^a   Imazu, Michinori ^b   Kihara, Yasuki ^c  

^a TSUCHIYA GENERAL HOSPITAL   (Japan)

^b Ajina Tsuchiya Hospital   (Japan)

^c HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Calcification; Dialysis; Rotational atherectomy; Sirolimus eluting stents

Indexed keywords

RAPAMYCIN;

ADVERSE OUTCOME; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BARE METAL STENT; CLINICAL TRIAL; CONTROLLED STUDY; DIALYSIS; DRUG ELUTING STENT; FEMALE; HAZARD RATIO; HEART INJURY; HUMAN; INCIDENCE; MAJOR ADVERSE CARDIAC EVENT; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; QUANTITATIVE STUDY; REVASCULARIZATION; RISK REDUCTION; ROTATIONAL ATHERECTOMY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ATHERECTOMY, CORONARY; CALCINOSIS; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; RENAL DIALYSIS; SIROLIMUS; STENTS; TREATMENT OUTCOME;

EID: 73249140950     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-09-0245     Document Type: Article

References (31)

1. Sharma SK, Israel DH, Kamean JL, Bodian CA, Ambrose JA. Clinical, angiographic, and procedural determinants of major and minor coronary dissection during angioplasty. Am Heart J 1993; 126: 39 - 47.
2. Alfonso F, Macaya C, Goicolea J, Hernandez R, Segovia J, Zamorano J, et al. Determinants of coronary compliance in patients with coronary artery disease: An intravascular ultrasound study. J Am Coll Cardiol 1994; 23: 879 - 884.
3. Bittl JA, Chew DP, Topol EJ, Kong DF, Califf RM. Meta-analysis of randomized trials of percutaneous transluminal coronary angioplasty versus atherectomy, cutting balloon atherotomy, or laser angioplasty. J Am Coll Cardiol 2004; 43: 936 - 942.
4. Moussa I, Di Mario C, Moses J, Reimers B, Di Francesco L, Martini G, et al. Coronary stenting after rotational atherectomy in calcified and complex lesions: Angiographic and clinical follow-up results. Circulation 1997; 96: 128 - 136.
5. Ryan TJ, Faxon DP, Gunnar RM, Kennedy JW, King SB 3rd, Loop FD, et al. Guidelines for percutaneous transluminal coronary angioplasty: A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). Circulation 1988; 78: 486 - 502.
6. Ellis SG, Vandormael MG, Cowley MJ, DiSciascio G, Deligonul U, Topol EJ, et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease: Implications for patient selection [Multivessel Angioplasty Prognosis Study Group]. Circulation 1990; 82: 1193 - 1202.
7. van der Zwet PM, Pinto IM, Serruys PW, Reiber JH. A new approach for the automated definition of path lines in digitized coronary angiograms. Int J Card Imaging 1990; 5: 75 - 83.
8. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, et al. Clinical end points in coronary stent trials: A case for standardized definitions. Circulation 2007; 115: 2344 - 2351.
9. Kimura T, Morimoto T, Nakagawa Y, Tamura T, Kadota K, Yasumoto H, et al. Antiplatelet therapy and stent thrombosis after sirolimuseluting stent implantation. Circulation 2009; 119: 987 - 995.
10. Imai E, Horio M, Nitta K, Yamagata K, Iseki K, Tsukamoto Y, et al. Modification of the Modification of Diet in Renal Disease (MDRD) Study equation for Japan. Am J Kidney Dis 2007; 50: 927 - 937.
11. Okada T, Hayashi Y, Toyofuku M, Imazu M, Otsuka M, Sakuma T, et al. One-year clinical outcomes of dialysis patients after implantation with sirolimus-eluting coronary stents. Circ J 2008; 72: 1430 - 1435.
12. Schwarz U, Buzello M, Ritz E, Stein G, Raabe G, Wiest G, et al. Morphology of coronary atherosclerotic lesions in patients with endstage renal failure. Nephrol Dial Transplant 2000; 15: 218 - 223.
13. Mintz GS, Weissman NJ. Intravascular ultrasound in the drug-eluting stent era. J Am Coll Cardiol 2006; 48: 421 - 429.
14. Rao SV, Honeycutt E, Kandzari D. Clinical outcomes with drugeluting stents following atheroablation therapies. J Invasive Cardiol 2006; 18: 393 - 396.
15. Khattab AA, Otto A, Hochadel M, Toelg R, Geist V, Richardt G. Drug-eluting stents versus bare metal stents following rotational atherectomy for heavily calcified coronary lesions: Late angiographic and clinical follow-up results. J Interv Cardiol 2007; 20: 100 - 106.
16. Das P, Moliterno DJ, Charnigo R, Mukherjee D, Steinhubl SR, Sneed JD, et al. Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularization. J Invasive Cardiol 2006; 18: 405 - 408.
17. Hassani SE, Chu WW, Wolfram RM, Kuchulakanti PK, Xue Z, Gevorkian N, et al. Clinical outcomes after percutaneous coronary intervention with drug-eluting stents in dialysis patients. J Invasive Cardiol 2006; 18: 273 - 277.
18. Halkin A, Selzer F, Marroquin O, Laskey W, Detre K, Cohen H. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs bare-metal stents in dialysis patients. J Invasive Cardiol 2006; 18: 577 - 583.
19. Ishio N, Kobayashi Y, Takebayashi H, Iijima Y, Kanda J, Nakayama T, et al. Impact of drug-eluting stents on clinical and angiographic outcomes in dialysis patients. Circ J 2007; 71: 1525 - 1529.
20. Aoyama T, Ishii H, Toriyama T, Takahashi H, Kasuga H, Murakami R, et al. Sirolimus-eluting stents vs bare metal stents for coronary intervention in Japanese patients with renal failure on hemodialysis. Circ J 2008; 72: 56 - 60.
21. Kuriyama N, Kobayashi Y, Nakayama T, Kuroda N, Komuro I. Images in cardiovascular medicine: Damage to polymer of a sirolimuseluting stent. Circulation 2006; 114: e586 - e587.
22. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, et al. Pathology of drug-eluting stents in humans: Delayed healing and late thrombotic risk. J Am Coll Cardiol 2006; 48: 193 - 202.
23. Tanigawa J, Barlis P, Di Mario C. Heavily calcified coronary lesions preclude strut apposition despite high pressure balloon dilatation and rotational atherectomy: In-vivo demonstration with optical coherence tomography. Circ J 2008; 72: 157 - 160.
24. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293: 2126 - 2130.
25. Kuchulakanti PK, Chu WW, Torguson R, Ohlmann P, Rha SW, Clavijo LC, et al. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation 2006; 113: 1108 - 1113.
26. Cook S, Wenaweser P, Togni M, Billinger M, Morger C, Seiler C, et al. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation 2007; 115: 2426 - 2434.
27. Park DW, Hong MK, Mintz GS, Lee CW, Song JM, Han KH, et al. Two-year follow-up of the quantitative angiographic and volumetric intravascular ultrasound analysis after nonpolymeric paclitaxel-eluting stent implantation: Late "catch-up" phenomenon from ASPECT Study. J Am Coll Cardiol 2006; 48: 2432 - 2439.
28. Kimura T, Abe K, Shizuta S, Odashiro K, Yoshida Y, Sakai K, et al. Long-term clinical and angiographic follow-up after coronary stent placement in native coronary arteries. Circulation 2002; 105: 2986 - 2991.
29. Aoki J, Abizaid AC, Serruys PW, Ong AT, Boersma E, Sousa JE, et al. Evaluation of four-year coronary artery response after sirolimus-eluting stent implantation using serial quantitative intravascular ultrasound and computer-assisted grayscale value analysis for plaque composition in event-free patients. J Am Coll Cardiol 2005; 46: 1670 - 1676.
30. Daemen J, Ong AT, Stefanini GG, Tsuchida K, Spindler H, Sianos G, et al. Three-year clinical follow-up of the unrestricted use of sirolimus-eluting stents as part of the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry. Am J Cardiol 2006; 98: 895 - 901.
31. Pinto DS, Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, et al. Impact of routine angiographic follow-up on the clinical benefits of paclitaxel-eluting stents: Results from the TAXUS-IV trial. J Am Coll Cardiol 2006; 48: 32 - 36.